Browser does not support script.
We make a powerful contribution to understanding how genetic abnormalities within cancer cells lead to disease. Through Birmingham’s Cancer Research UK Clinical Trials Unit- one of Europe’s leading clinical trials unit- we use this information to design and rigorously assess new and proven cancer treatments. In so doing, we will play a significant role in accelerating the ultimate control of cancer.
Scientists set to benefit from one of the biggest grants awarded by Cancer Research UK
New molecular mechanism revealed for genetic mutations in aggressive cancer cells
Scientists closer to understanding the role of certain genes in breast cancer
MP dons lab coat to learn how research saves lives
Life Sciences in Six - Dr Joanna Parish
My story: Graham Silk
Precision Medicine: Diagnostic medical genetics
Dr Andrew Peet - Support our brain cancer in children research
Posted 27 September 2017
A genetic fault has been identified in people with an aggressive type of leukaemia that can significantly affect how they respond to treatment.
Posted 12 September 2017
A scientist at the University of Birmingham has received a £1.4 million award from Cancer Research UK to carry out pioneering research that may discover how cancer 'steals the keys' from the body's locksmiths, disrupting healthy cell growth and function.
Posted 21 August 2017
Professor Dion Morton, Director of the Experimental Cancer Medicine Centre at the University of Birmingham, writes for the NIHR Blog on how the NIHR health research system has supported innovative research in his area of cancer surgery.
Posted 14 July 2017
The College of Medical and Dental Sciences is delighted to announce that at the University of Birmingham Founders' Awards for Excellence 2017, held on Thursday 12 July during the Chancellor's Dinner, colleagues from across the College were awarded three of the evening's four awards.
The National Institute for Health Research (NIHR) has awarded £7 million to the Universities of Birmingham, Edinburgh and Warwick to establish a joint research unit focussed on developing global surgical research.
View all news